According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are ยฃ70.32 Million. In 2025 the company made an earning of -ยฃ29.78 Million, an increase over its 2024 earnings that were of -ยฃ52.57 Million. The earnings displayed on this page is the company's Pretax Income.